Pharmaceutical Lipid-Based Excipients Market To Reach $2.42 Billion By 2030

Pharmaceutical Lipid-based Excipients Market Growth & Trends

The global pharmaceutical lipid-based excipients market size is anticipated to reach USD 2.42 billion by 2030 and is anticipated to expand at a CAGR of 4.8% during the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of poorly soluble drug candidates, representing 87% of pipeline candidates, has driven the adoption of advanced excipient solutions. Lipid-based excipients such as solid lipid nanoparticles and self-emulsifying drug delivery systems have become essential for complex molecules, addressing formulation challenges effectively. This surge reflects the pharmaceutical industry’s need for innovative solutions to enhance drug bioavailability and efficacy.

The integration of lipid-based excipients has revolutionized mRNA vaccines and gene therapies, as highlighted during the COVID-19 pandemic. Moreover, the demand for cost-effective excipients has further increased due to patent expirations for major pharmaceutical drugs. These factors underscore the transformative impact of lipid excipients on modern pharmaceutical development and their role in driving innovation in drug delivery.

Advancements in artificial intelligence (AI) and formulation technologies further contribute to the growth of the lipid excipients market. AI-driven modeling accelerates lipid based formulations, enhancing predictability and reducing time-to-market. Regulatory bodies maintain high expectations for lipid excipients, prioritizing patient safety by focusing on purity and safety characteristics, ultimately ensuring the quality and effectiveness of pharmaceutical products.

 Request a free sample copy or view report summary: Pharmaceutical Lipid-Based Excipients Market Report

Pharmaceutical Lipid-based Excipients Market Report Highlights

• Based on excipients, oil excipients dominated the market in 2024, accounting for 40.5% of the total revenue due to advancements in lipid drug delivery, nutraceutical use, and demand for sustainable ingredients.

• The lecithin and phospholipids segment is projected to grow at a robust CAGR over the forecast period.

• Based on product applications, topical formulations led the market with the largest revenue share in 2024; however, ophthalmic applications are expected to grow at the fastest rate of 6.7% over the forecast period.

• Based on disease, oncological applications of lipid-based excipients garnered the largest revenue in 2024, aided by a growing pipeline of targeted therapies and immunotherapies for cancer.

• Based on industry, the nutraceutical (dietary supplements & others) segment is expected to witness the fastest CAGR over the forecast period, fueled by strategic partnerships between lipid excipient manufacturers and supplement-focused pharmaceutical companies.

• As aging-related conditions become more widespread, the geriatric products (65+ years) segment is expected to witness the fastest CAGR of over 5.0% over the forecast period.

• Based on end use, pharmaceutical manufacturers emerged as dominant end users in the market in 2024, accounting for 64.9% of the total revenue.

• In April 2024, IOI Oleo GmbH launched DYNASAN CrystalCONTROL L for the cosmetics industry. This product addresses the “blooming” effect in stick formulations, improving product stability and aesthetics for a worry-free process globally.

Pharmaceutical Lipid-based Excipients Market Segmentation

Grand View Research has segmented the global pharmaceutical lipid-based excipients market on the basis of excipient type, product applications, disease application, industry application, age group, end-use, and region:

Pharmaceutical Lipid-based Excipients Type Outlook (Revenue, USD Million, 2018 - 2030)

• Oils

  • Sesame Oil

  • Soybean Oil

  • Sunflower Oil

  • Linseed Oil / Flaxseed Oil

  • Safflower Oil

  • Coconut Oil

  • Arachis Oil / Peanut Oil

  • Corn Oil / Maize Oil

  • Olive Oil

  • Almond Oil

  • Castor Oil

  • Cotton Seed Oil

  • Grapeseed Oil

  • Other Oils

• Hydrogenated Vegetable Oils

• GMCC (Glyceryl Monostearate)

• Hard Fats

• Medium Chain Triglycerides (MCTs)

• Lecithin and Phospholipids

• Sodium Oleate

• Capri Caprylic Mono Diglyceride

• Others

Pharmaceutical Lipid-based Excipients Product Application Outlook (Revenue, USD Million, 2018 - 2030)

• Oral Formulations

  • Softgel Capsules

  • Solid Dosage (Tablet, capsules, & pills)

  • Liquid Oral

  • Solid Lipid Nanoparticles (SLNs)

• Parenteral

  • Small Volume Parenteral

  • Large Volume Parenteral

• Topical Applications

  • Creams

  • Ointments

  • Others

• Ophthalmic Applications

  • Eye Drops

  • Ocular Emulsions

• Suppositories

  • Rectal Suppositories

  • Vaginal Suppositories

  • Other Suppositories

• Others

Pharmaceutical Lipid-based Excipients Disease Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiovascular Diseases

• Neurological Disorders

• Oncology

• Metabolic Disorders

• Hormonal Therapies

• Infectious Diseases

Pharmaceutical Lipid-based Excipients Industry Application Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical (OTC & Rx)

• Nutraceutical (Dietary Supplements & Others)

Pharmaceutical Lipid-based Excipients Age Group Outlook (Revenue, USD Million, 2018 - 2030)

• Pediatric Products (0-18 years)

• Adult Products (19-64 years)

• Geriatric Products (65+ years)

Pharmaceutical Lipid-based Excipients End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical Manufacturers

• Contract Development and Manufacturing Organizations (CDMOs)

• Others

Pharmaceutical Lipid-based Excipients Region Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Thailand

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Jordan

  • Egypt

  • Iran

  • Kuwait

List of Key Players in the Pharmaceutical Lipid-based Excipients Market

• ABITEC Corporation

• BASF

• Gattefossé

• CordenPharma

• Lipoid

• IOI Oleo GmbH

• Croda International

• Evonik Industries

• Ashland

• Merck KGaA